Thailand ramps up Mpox monitoring, especially in key tourist areas
January 16, 2026
Thailand’s mpox response shows what sustained, risk-informed public health action looks like after headlines fade. By pairing surveillance with targeted outreach, the Department of Disease Control has acknowledged the epidemiologic reality that close contact, including sexual contact, is driving transmission. Strategic vaccine allocation to high-risk areas and populations reflects pragmatic prevention, not stigma. Continued public education, early care-seeking, and transparent guidance from the Ministry of Public Health are essential to keep localized outbreaks from becoming entrenched, especially in tourism-heavy regions.
Thailand’s approach to mpox offers a measured example of how countries can manage persistent transmission without resorting to crisis-driven responses. Since 2022, the country has recorded roughly 1,000 cases, predominantly among working-age men, with surveillance consistently identifying close contact, often sexual contact with unfamiliar partners, as the primary risk factor. Rather than obscuring this pattern, the Department of Disease Control has integrated it into prevention strategy.
Cases detected in major tourist destinations underscore the dual challenge Thailand faces. High population mobility increases exposure risk, while tourism-dependent economies must balance disease control with public confidence. The response has centered on strengthened surveillance, epidemiologic investigation, and proactive outreach to groups with higher-risk behaviors. Public education on mpox, HIV, and other sexually transmitted infections, alongside promotion of safer sex practices, reflects an integrated sexual health framework rather than a siloed outbreak response.
Vaccine deployment further illustrates this pragmatism. With support from ASEAN, Thailand has received a limited supply of mpox vaccine and prioritized distribution to healthcare workers and individuals at elevated risk in Bangkok, Chon Buri, Chiang Mai, and Phuket. This targeted allocation recognizes that when supply is constrained, precision matters more than scale.
Public guidance has remained straightforward and actionable, emphasizing symptom recognition, hygiene, and avoidance of close contact with individuals who have suspicious rashes or lesions. Encouraging early medical evaluation helps reduce onward transmission and supports timely care.
Thailand’s experience reinforces a broader lesson. Mpox is no longer an emergency, but it is not over. Effective control depends on sustained surveillance, honest risk communication, and equitable access to prevention tools. Managing mpox successfully now requires consistency, not urgency, and Thailand’s response reflects that reality.